APA (7th ed.) Citation

D, L., B, K., G, K., B, K., C, S., R, F., . . . JS, S. (2026). Clinically translatable anti-fibrotic nanosuspension for inhaled treatment of idiopathic pulmonary fibrosis. Drug delivery and translational research, 16(5), 1581. https://doi.org/10.1007/s13346-025-01973-y

Chicago Style (17th ed.) Citation

D, Lee, Kong B, Kwak G, Kang B, Swaby C, Fanaroff R, Sidhaye V, and Suk JS. "Clinically Translatable Anti-fibrotic Nanosuspension for Inhaled Treatment of Idiopathic Pulmonary Fibrosis." Drug Delivery and Translational Research 16, no. 5 (2026): 1581. https://doi.org/10.1007/s13346-025-01973-y.

MLA (9th ed.) Citation

D, Lee, et al. "Clinically Translatable Anti-fibrotic Nanosuspension for Inhaled Treatment of Idiopathic Pulmonary Fibrosis." Drug Delivery and Translational Research, vol. 16, no. 5, 2026, p. 1581, https://doi.org/10.1007/s13346-025-01973-y.